Corrigendum to “CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis” [Clin. Immunol. 136 (2010) 139–147]
Autor: | Richter, J., Benson, V., Grobarova, V., Svoboda, J., Vencovsky, J., Svobodova, R., Fiserova, A. |
---|---|
Zdroj: | In Clinical Immunology March 2015 157(1):102-102 |
Databáze: | ScienceDirect |
Externí odkaz: |